Integrating oral immunotherapy into clinical practice

In 2020, the first food allergy treatment, an oral immunotherapy (OIT) product for peanut allergy, was approved by the Food and Drug Administration, and a peanut epicutaneous immunotherapy patch was under review. As food allergy therapies become available and widespread, allergy offices will need to adjust practices to be able to offer their patients these new treatments. OIT is an intensive therapy that requires commitment from patients and their families, and open communication with the practice is paramount.

Source: Journal of Allergy and Clinical Immunology - January 1, 2021 Category: Allergy & Immunology Authors: Stephanie A. Leonard, Susan Laubach, Julie Wang Tags: Reviews and feature article Source Type: research